Roze bril schreef op 12 december 2019 10:47:
[...]
Volgens het persbericht verlaat Holmes Kiadis om andere uitdagingen aan te gaan....
Amsterdam, The Netherlands, December 11, 2019 – Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that Scott A. Holmes, the Company’s chief financial officer and member of the Company’s management board, is stepping down to pursue other opportunities. Mr. Holmes’ resignation will be effective December 31, 2019.
M.a.w. hij stapt zelf op...